Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels

BACKGROUND: The integrin-binding protein osteopontin is strongly associated with tumour development, yet is an abundant dietary component as a constituent of human and bovine milk. Therefore, we tested the effect of orally administered osteopontin (o-OPN) on the development of subcutaneous tumours i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rittling, S R, Wejse, P L, Yagiz, K, Warot, G A, Hui, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950862/
https://www.ncbi.nlm.nih.gov/pubmed/24473400
http://dx.doi.org/10.1038/bjc.2014.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950862/
https://www.ncbi.nlm.nih.gov/pubmed/24473400
http://dx.doi.org/10.1038/bjc.2014.10

Ejemplares similares